Porton Pharma Solutions Ltd. (SHE:300363)

China flag China · Delayed Price · Currency is CNY
21.88
+0.47 (2.20%)
Apr 28, 2026, 3:04 PM CST
Market Cap11.86B +24.3%
Revenue (ttm)3.50B +11.8%
Net Income128.49M
EPS0.23
Shares Out542.18M
PE Ratio96.63
Forward PE59.14
Dividend0.09 (0.42%)
Ex-Dividend Daten/a
Volume27,578,889
Average Volume14,624,182
Open21.11
Previous Close21.41
Day's Range21.11 - 23.00
52-Week Range14.53 - 30.40
Beta0.70
RSI52.27
Earnings DateApr 4, 2026

About Porton Pharma Solutions

Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial in China and internationally. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. It also offers crystallization, bio catalysis, metal catalysis, flow chemistry, prep-chromatograph... [Read more]

Sector Healthcare
Founded 2005
Employees 4,359
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300363
Full Company Profile

Financial Performance

Financial Statements